Clinical trial
Cysteine Supplementation in Critically Ill Neonates
NCT00254176 · University of California, Los Angeles, Other · Unknown status
Key facts
| NCT number | NCT00254176 |
|---|---|
| Title | Cysteine Supplementation in Critically Ill Neonates |
| Official title | Effect of Cysteine Supplementation on Glutathione Production in Critically Ill Neonates |
| Lead sponsor | University of California, Los Angeles, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Sepsis, Bronchopulmonary Dysplasia, Necrotizing Enterocolitis, Retinopathy of Prematurity, Systemic Inflammatory Response Syndrome |
| Intervention type | Dietary Supplement |
| Interventions | Parenteral cysteine-HCl supplementation, Placebo - added premasol |
| Enrollment | 108 |
| Start date | Sep 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Nov 15, 2005 |
| Last update posted | Feb 26, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: